Some pharmacokinetic parameters of ampicillin/sulbactam combination after intravenous and intramuscular administration to goats

Veterinary Quarterly

Volumn 18, Issue 4, 1996, Pages 136-140

  Espuny, A ^a   Carceles, C M ^a   Vicente, M S ^a   Escudero, E ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SULTAMICILLIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; GOAT; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN;

AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; BODY WEIGHT; DRUG COMBINATIONS; FEMALE; GOATS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; SULBACTAM; TIME FACTORS;

ANIMALIA; CAPRA HIRCUS;

EID: 0030319538     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.1996.9694635     Document Type: Article

References (33)

1. Anika SM, Nouws JFM, Gogh H van, Nieuwenhuijs J, Vree TB, and Miert ASJPAM van. Chemotherapy and pharmacokinetics of some antimicrobials agents in healthy dwarf goats and those infected with Ehrlichia phagocytophila (tick-borne fever). Res Vet Sci 1986; 41: 386–90.
2. Baggot JD. Principles of drug disposition in domestic animals: The basis of veterinary clinical pharmacology. WB Saunders Company, Philadelphia, 1977: 190–218.
3. Bawdon RE, and Madsen PO. High-pressure liquid chromatographic assay of sulbactam in plasma, urine, and tissue. Antimicrob Agents Chemoth 1986; 30: 231–3.
4. Bentley OE, and Cummins JM. Efficacy ofsulbactam, a 13-lactamase inhibitor, combined with ampicillin in the therapy of ampicillin-resistant pneumonic pasteurellosis in feedlot calves. Can Vet J 1987; 9: 591–9.
5. Blum RA, Kohli RK, Harrison NJ, and Schentag JJ. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 grams) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis. Antimicrob Agents Chemoth 1989; 9: 1470–6.
6. Bundtzen RW, Andreas UG, Cohn DL, and Craig WA. Postantibiotic suppression of bacterial growth. Rev Infect Dis 1981; 3: 28–37.
7. Campoli-Richards DM, Brodgen RN. Sulbactam/ampicillin: a review of its antibacterial activity, pharmacokinetic properties, and therapeutic use. Drugs 1987; 33: 577–609.
8. Dorrestein GM, Gogh H van, Rinzema JD, and Buitelaar MN. Comparative study of ampicillin and amoxycillin after intravenous, intramuscular and oral administration in homing pigeons (Columba livia). Res Vet Sci 1987; 42: 343–8.
9. Ekstrom B. The prodrug principle applied to antibiotics. Drugs Exp Clin Res 1981; 7: 269–76.
10. English AR, Girard D, Cimochowski C, Faiella J, Retsema JA, and Lynch JE. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection. Rev Infect Dis 1986; 8: S535–42.
11. Ensink JM, Klein WR, Mevius DJ, Klarenbeek A, and Vulto AG. Bioavailability of oral penicillins in the horse: a comparation of pivampicillin and amoxicillin. J Vet Pharmacol Ther 1992; 15: 221–30.
12. Farrington DO, Jackson JA, Bently OE, and Barns HJ. Efficacy of sulbactam-ampicillin in an induced Pasteurella haemolytica pneumonia model in calves. Am J Vet Res 1987; 12: 1684–8.
13. Fales WH, Selby LA, Webber JJ, Hoffman LJ, Kintner LD, Nelson SL, Miller RB, Thorne JGM, McGinity JT, and Smith DK. Antimicrobial resistance among Pasteurella spp recovered from Missouri and Iowa cattle with bovine respiratory disease complex. J Am Vet Med Assoc 1982; 5: 477–9.
14. Foulds G, Stankewich JP, Marshall DC, O’Brien MM, Hayes SL, Weidler DJ, and McMamon FG. Pharmacokinetics of sulbactam in humans. Antimicrob Agents Chemother 1983; 23: 692–9.
15. Girard AE, Schelky WU, Murphy KT, and Sawyer PS. Activity of 13-lactamase inhibitor sulbactam plus ampicillin against animals isolates of Pasteurella, Haemophilus, and Staphylococcus. Am J Vet Res 1987; 48: 1678–83.
16. Grimshaw WTR, and Colman PJ. The plasma kinetics of sulbactam & ampicillin administered to calves by intramuscular and subcutaneous routes. Brit Vet J 1987; 143: 361–8.
17. Khanikor HN, Srivastava AK, Paul BS, and Malik JK. Pharmacokinetics of ampicillin and amoxicillin in Bubalus bubalis following intramuscular administration. Acta Vet Hung 1986; 34: 225–30.
18. Lode H. Introduction to the symposium on rational parameters of antibiotic treatment. Infection 1980; 8: 5.
19. Loo JCK, and Riegelman S. New method for calculating the intrinsic absorption rate of drugs. J Pharm Sci 1968; 57: 918–28.
20. Montesissa C, Villa R, Sonzogni O, Belloli C, and Carli S. Cornparative pharmacokinetics of ampicillin-sulbactam combination in calves and sheep. J Vet Pharm Therap 1994; 17: 359–64.
21. Nouws JFM, Ginneken CAM van, Hekman P, andZiv G. Comparative plasma ampicillin levels and bioavailability offive parenteral ampicillin formulations in ruminant calves. Vet Quart 1982; 4: 63–71.
22. Oukessou M, and Toutain PL. Effect of water deprivation on absorption (oral, intramuscular) and disposition of ampicillin in sheep. J Vet Pharm Therap 1992; 15: 421–32.
23. Powers J. Statistical analysis of pharmacokinetic data. J Vet Pharm Therap 1990; 13: 113–20.
24. Retsema JA, Schelky WU, Girard AE, and English AR. Beta-lactamase inhibitor CP-45,899 (sulbactam) mode of actions against type III beta-lactamase and synergy effects with cephalosporins. Drugs Exp Clin Res 1981; 7: 255–61.
25. Retsema JA, English AR, Girard AE, Lynch JE, Anderson M, Brennan L, Cimochowski C, Faiella J, Norcia W, and Sawyer P. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection. Rev Infect Dis 1986; 8: S528–34.
26. Rudrik JT, and Bawdon RE. Determination of penicillinase resistant penicillins in plasma using high pressure liquid chromatography. J Liq Chromatogr 1981; 4: 1525–45.
27. Sarasola P, and McKellar QA. Pharmacokinetics and applications of ampicillin sodium as an intravenous infusion in the horse. J Vet Pharm Therap 1993; 16: 63–9.
28. Shumaker RC. PKCALC: a basic interactive computer program for statistical and pharmacokinetics analysis of data. Drug Metab Rev 1986; 17: 331–48.
29. Sykes RB, and Matthew M. The beta-lactamases of Gram negative bacteria and their role in resistance to beta-lactam antibiotics. J Antimicrob Chemoth 1976; 2: 115–57.
30. Tufenkji AE, Alvinerie M, Larrieu G, Houin G, and Galtier P. Pharmacokinetics of ampicillin and pentobarbital in the course of subclinical fasioliasis in sheep. Res Vet Sci 1991; 50: 75–80.
31. Wagner JG. Farmacocinética clinica. Ed Reverté, S.A. Barcelona 1983: 175–204.
32. Washburn RG, and Durak DT. Efficacy of ampicillin plus a 13-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus. J Infect Dis 1981; 144: 237–43.
33. Yamaoka K, Nakagawa T, and Uno T. Application of Akaike’s Information Criterion (AIC) in the evaluation oflinear pharmacokinetic equations. J Pharm Biopharm 1978; 6: 165–75.